$Petros Pharmaceuticals(PTPI.US$
Q4 虛擬峰會:彼得羅斯
2021 年十一月十七日下午一時十五分
https://us06web.zoom.us/webinar/register/WN_NTIn4DtgSECPTyy4hE_YEg
Q4 虛擬峰會:彼得羅斯
2021 年十一月十七日下午一時十五分
https://us06web.zoom.us/webinar/register/WN_NTIn4DtgSECPTyy4hE_YEg
已翻譯
1
$Petros Pharmaceuticals(PTPI.US$
Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today the expansion of its program for investigational H100, a novel patented non-invasive topical treatment under development for Peyronie's disease. H100 is a topical gel formulated to address the inflammatory cascade that leads to pain, scarring and penile irregularities associated with Peyronie's disease. Through its exclusive global license agre...
Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today the expansion of its program for investigational H100, a novel patented non-invasive topical treatment under development for Peyronie's disease. H100 is a topical gel formulated to address the inflammatory cascade that leads to pain, scarring and penile irregularities associated with Peyronie's disease. Through its exclusive global license agre...
1
已翻譯
1
2
$Petros Pharmaceuticals(PTPI.US$
彼得羅斯製藥股份有限公司通過與希姆斯 & Hers 健康有限公司的獨家營銷協議,創造了 STENDRA 平板片銷售額同比增長 476%
彼得羅斯製藥股份有限公司通過與希姆斯 & Hers 健康有限公司的獨家營銷協議,創造了 STENDRA 平板片銷售額同比增長 476%
已翻譯